Title : Bempedoic Acid (ETC-1002): A Current Review.

Pub. Date : 2018 May

PMID : 29609755






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Bempedoic acid (ETC-1002) is a novel once-daily LDL-C-lowering agent in phase 3 clinical trials. 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid component of oligomeric golgi complex 2 Homo sapiens
2 Bempedoic acid (ETC-1002) is a novel once-daily LDL-C-lowering agent in phase 3 clinical trials. 8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid component of oligomeric golgi complex 2 Homo sapiens